Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Emerging Views On Emerging Markets: Goldman Sachs Global Healthcare Conference

This article was originally published in PharmAsia News

Executive Summary

In this periodic feature, PharmAsia News listens in at major industry events to hear what senior executives have to say about Asia and other emerging markets. In our last profile, we sat in on a recent Sanford Bernstein conference in New York ('Emerging Views On Emerging Markets: The Sanford Bernstein Strategic Decisions Conference,' June 7, 2011). For this profile, we zoom in on the 32nd annual Goldman Sachs Global Healthcare Conference, held June 7-9 in Rancho Palos Verdes, California.
Advertisement

Related Content

Emerging Views On Emerging Markets: Morgan Stanley Global Healthcare Conference
What Pricing Pressure? Recordati Continues Push Into Turkey With Latest Acquisition
Back To The Future: Gilead Signs Up Four Indian Companies To License Late-stage AIDS Therapies
Emerging Views On Emerging Markets: The Sanford Bernstein Strategic Decisions Conference
Emerging Views On Emerging Markets: The Sanford Bernstein Strategic Decisions Conference
Boehringer Threatens Turkish Exit Due To Price Cuts
Will Innovation Replace Branded Generics As Dominant Strategy For Big Pharma In Emerging Markets? (Part 2 of 2)
Abbott, Eli Lilly, Novartis: Emerging Markets Earnings Round Up (Part 1)
Piramal Deal Done, Abbott's India Plunge May Fetch Big Returns, But Integration Challenges, Growth Momentum Critical
Gilead Fights For Viread Patent And Royalties In India
Advertisement
UsernamePublicRestriction

Register

SC078212

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel